Greater MVPA was modestly associated with better QoL, with stronger associations observed in survivors receiving hormone therapy or >24 months postdiagnosis. There are potential QoL benefits in implementing interventions immediately postdiagnosis and tailoring to treatment histories.
Schleicher et al. (Thu,) studied this question.